In a significant move to enhance its induced pluripotent stem cell (iPSC) technology portfolio, Axol Bioscience has announced the complete acquisition of French biotechnology firm Phenocell SAS, marking a strategic expansion into ophthalmology and dermatology research models.
September 13 – 26, 2025 Orlando, USA
September 10 – 12, 2025 Columbus, USA
September 6 – 10, 2025 Vienna, Austria
July 16 – 18, 2025 Kuala Lumpur, Malaysia
May 18 – 22, 2025 Brussels, Belgium
April 25 – 30, 2025 Chicago, USA
March 25 – 27, 2025 Paris, France
If you would like first-hand information, we will be available for a meeting at MEDICA in Düsseldorf. Contact us at support@3diag.com
MINI 96 96 Channel Portable Electronic Pipette
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
